Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Rodenko

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Plos One|June 23, 2016
Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of ImmunodominanceSietske K Rosendahl Huber, Jolien J Luimstra, Josine van Beek, et al.
Nature Medicine|February 8, 2006
Design and use of conditional MHC class I ligandsMireille Toebes, Miriam Coccoris, Adriaan Bins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2008
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7Arnold H Bakker, Rieuwert Hoppes, Carsten Linnemann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activityBoris Rodenko, Mohammed I Al-Salabi, Ibrahim A Teka, et al.
Cell Chemical Biology|May 30, 2017
Proteasome Activation by Small MoleculesYves Leestemaker, Annemieke de Jong, Katharina F Witting, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2014
Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopesRieuwert Hoppes, Rimke Oostvogels, Jolien J Luimstra, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2013
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasisChristophe J Desmet, Tristan Gallenne, Alexandre Prieur, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Plos One|June 23, 2016
Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of ImmunodominanceSietske K Rosendahl Huber, Jolien J Luimstra, Josine van Beek, et al.
Nature Medicine|February 8, 2006
Design and use of conditional MHC class I ligandsMireille Toebes, Miriam Coccoris, Adriaan Bins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2008
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7Arnold H Bakker, Rieuwert Hoppes, Carsten Linnemann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activityBoris Rodenko, Mohammed I Al-Salabi, Ibrahim A Teka, et al.
Cell Chemical Biology|May 30, 2017
Proteasome Activation by Small MoleculesYves Leestemaker, Annemieke de Jong, Katharina F Witting, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 2014
Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopesRieuwert Hoppes, Rimke Oostvogels, Jolien J Luimstra, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2013
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasisChristophe J Desmet, Tristan Gallenne, Alexandre Prieur, et al.
Pageof 3